Cisbio Bioassays Introduces Tag-lite® Multi-Mode Cell Lines
March 9, 2010
Multiple assays can now be run using same cellular material - Company continues to enhance Tag-lite platform for a complete drug discovery solution Bagnols-sur-Cèze, France – Cisbio Bioassays (www.htrf.com), a member of IBA group and global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, today announced that [...]
PTI Celebrates 25 Years in 2010
March 9, 2010
Protein Technologies (PTI) celebrates its 25th anniversary this year of providing quality products and service to the global peptide community. PTI’s very first peptide synthesizer, the PS3™, celebrates its 20th anniversary in 2010 thanks to the reliability and no-nonsense operation that has come to characterize all PTI instruments since then. A fantastic basic unit, it [...]
Universal Detection Technology Receives Purchase Order From the City of Burbank Fire Department
March 9, 2010
Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, and provider of counter-terrorism consulting and training services, reported today that it has received a purchase order from the City of Burbank Fire Department for its bioterrorism detection equipment. The purchase order includes [...]
Uniqsis Selects Teledyne Isco as Service Provider
March 9, 2010
Cambridge, Cambs, United Kingdom -- Innovative continuous flow reactor manufacturer, Uniqsis Ltd of Cambridge, UK is to utilize the service capabilities of Teledyne Isco, Inc. in the USA. Teledyne Isco will provide post-installation field, depot and warranty repair services, as well as equipment repair service consultation via telephone in the USA for Uniqsis FlowSyn Continuous [...]
Promega – TOP srl Agreement Enables Live Animal Imaging for Cancer Studies
March 9, 2010
MADISON, Wis.--Promega and TOP srl have combined their industry leading technologies to provide the most sensitive tools for monitoring apoptosis in live mammals, an important biomarker in cancer studies. Under the agreement, the two companies are promoting the VivoGlo™ Caspase 3/7 Substrate for use with transgenic repTOPTM reporter mice. The tools allow the direct visualization [...]
Accelerating Cell-Based ELISA Procedures
March 9, 2010
Agilent Automation Solutions has announced a configuration of its BioCel System that allows laboratories to fully automate cell-based ELISA procedures thereby reducing the risk of human error, contamination and time spent on tedious manual procedures. The handling of cells in automated systems requires smooth and reliable operation and specialized equipment. Agilent Automation Solutions designed this [...]
March 9, 2010
Revolutionise your Analysis of Biomolecular Interaction The new SPRi-Plex II™ from HORIBA Scientific revolutionises the way researchers and analysts are able to utilise label free bio-affinity analyses. The Surface Plasmon Resonance imaging technology developed for the HORIBA SPRi-Plex adds high-throughput, real-time kinetic and affinity studies to bio-molecule arrays. This enhanced system will allow you to: [...]
PTI Achieves Double-Digit Growth for 3rd Year in a Row
March 9, 2010
Protein Technologies has done it again! Achieving double-digit growth for a company even in good times is an amazing feat. It is an extraordinary one in financial times like these, and PTI has now done it for the third year in a row! 2009 was a fabulous year for Protein Technologies. It broke its record [...]
Odyssey Thera Announces Agreement with Lonza
March 9, 2010
SAN RAMON, Calif. -- Odyssey Thera, Inc., announced today the signing of an agreement with Lonza to make Odyssey Thera's proprietary Protein-fragment Complementation Assay (PCA) technology, as part of compound profiling services, available to life science and drug discovery researchers. Additionally, Odyssey Thera has granted to Lonza an option to certain exclusive global technology licenses. [...]
Source BioScience orders UK’s first Illumina HiSeq 2000
March 9, 2010
Source BioScience plc (LSE: SBS), the provider of expert, quality services to the life science research, pharma biotech and healthcare sectors, is pleased to announce the purchase of Illumina's new HiSeq 2000 high throughput next generation sequencing platform, the first laboratory in the UK to do so. This investment will further strengthen Source BioScience's existing [...]
